The 13th World Congress on Bioavailability & Bioequivalence covers topics such as:
- Bioequivalence
- Bioavailability
- Regulatory Requirements for Bioequivalence
- Factors Affecting Bioavailability
- Study Designs
- Bioequivalence Protocols: In vivo/ In vitro studies
- Significance of BA/BE Studies
- BA/BE studies of Biologics and Biosimilars
- Clinical Pharmacology and Therapeutics
- Clinical Trails
- Drug Metabolism
- Challenges in Drug Design and Development
- Pharmacology- PK & PD approach
- Biosimilars
- Clinical Research Vs Clinical Trails
- Pharmaceutical Formulations
- Recent approaches to Biosimilars
- BCS & IVIVC Based Bio waivers
- Drug Safety
The 13th World Congress on Bioavailability & Bioequivalence will be held in Singapore on 11-12 July 2022.
